SkinMed
SkinMed Limited is a UK-based medical aesthetics company that develops medically licensed skin treatment protocols (Rosagate, Tebiskin OSK, Closebax, EnerPeel) and sells them exclusively to medically-led aesthetic clinics through direct B2B sales, supported by CPD-accredited training and managed marketing services.
- Company typePrivate
- Founded2021
- HeadquartersHarrogate, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SkinMed does
SkinMed Limited is a UK-based, privately held medical aesthetics company operating from Harrogate, North Yorkshire, that develops and distributes medically licensed dermatological protocols and products exclusively to medically-led aesthetic clinics across the United Kingdom. Its core technology stack is built around patented EnerPeel Carrier Technology (a delivery system for chemical peels), proprietary peptide and formulation chemistry including RO-peptide 23 (a direct KLK5/KLK7 inhibitor targeting cathelicidin processing in rosacea), Triethyl Citrate plus oligopeptide-10 acne formulations (Tebiskin OSK), Retimitate (a retinoic-acid equivalent without side effects), and microbiome-modulating seborrhoeic dermatitis products (Closebax). These components feed trademarked, multi-modal protocols such as the TripleLock Rosacea Protocol and Rosagate Transformation, each backed by clinical studies conducted in teaching hospitals across Italy, France, the Netherlands, Greece, Germany, and the UK.
The company's business model is a B2B direct-sales motion targeting doctor-, nurse-, and dermatologist-led clinics. Clinics purchase initial orders exceeding £500 (paid upfront before delivery), receive up to 80% discount on peels and 50%+ on Tebiskin products versus RRP, and resell treatments at retail. SkinMed monetizes across three streams: medical product sales, Level 5-7 CPD-accredited training via SkinMed Academy (£500 per session with £250 redeemable against opening orders), and trademarked protocol licensing (ARAUK accreditation pathway co-financed with the Acne and Rosacea Association UK). The company operates its own warehouse and distribution, and provides a managed marketing suite (bespoke landing pages, Meta advertising campaigns, email promotion, and creative assets) to drive patient footfall into partner clinics, targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.
SkinMed monetizes its intellectual property and clinical evidence base through a high-touch partner ecosystem: 11-50 employees support a network of accredited clinics, with senior clinical authority anchored by Professor Tony Chu (President of ARAUK, 45+ years of dermatology experience). The company has no disclosed external funding, no subsidiaries, and no public market listing, and it has been actively extending its product surface in 2025 with Rosagate rosacea treatments, an acne in-clinic treatment plus overnight mask, and the consumer-facing SkinVital vitamin line, while maintaining strict medically-licensed product positioning.
SkinMed firmographics
Firmographics- Name
- SkinMed
- Legal name
- SkinMed Limited
- Website
- https://skinmed.co.uk
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SkinMed Limited is a UK-based medical aesthetics company that develops medically licensed skin treatment protocols (Rosagate, Tebiskin OSK, Closebax, EnerPeel) and sells them exclusively to medically-led aesthetic clinics through direct B2B sales, supported by CPD-accredited training and managed marketing services.
- Ownership category
- akta.pro rank
SkinMed industry classification
Industry- Product category
- Medical Aesthetics Skincare
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where SkinMed is headquartered
LocationHeadquarters
- HQ city
- Harrogate
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
SkinMed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Others
Revenue model
- Medical Product Sales: SkinMed sells medically licensed skincare products and protocols to accredited aesthetic clinics. Products include Tebiskin range, EnerPeel peels, Rosagate professional and homecare products, and Closebax. Clinics purchase at significant discounts (up to 80% off RRP) and sell treatments at recommended retail prices.
- Professional Training Services: Level 7 CPD-accredited training programmes delivered through SkinMed Academy. Training costs £500 ex VAT per session with £250 redeemable against opening orders. Includes ARAUK accreditation, scarring masterclass, and advanced skin science courses. Additional course modules available individually.
- Protocol Licensing: SkinMed provides trademarked SkinMed Protocols to trained and accredited clinics, including the TripleLock Rosacea Protocol and acne treatment protocols. Clinics gain access to evidence-based clinical protocols developed by SkinMed.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | One time/ perpetual license | Professional Training Session |
| Unit Pricing | Pay-as-you-go | Clinic Opening Order |
| Unit Pricing | Pay-as-you-go | Derma FNS Device |
| One time/ perpetual license | One time/ perpetual license | ARAUK Accreditation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
SkinMed product offering
Product offeringCore offering
SkinMed develops and supplies medically licensed skin treatment protocols, proprietary topical formulations, chemical peels, dermal needling devices, and clinically validated product ranges (Rosagate, Tebiskin OSK, Closebax, EnerPeel) exclusively to medically led aesthetic clinics in the UK. The company also operates the SkinMed Academy for CPD-accredited clinical training and a marketing suite that provides paid advertising, bespoke landing pages, and patient referral support to partner clinics.
Product overview
SkinMed is a medically-focused dermatology company offering a portfolio of clinically-proven, medically licensed skin solutions primarily for medically-led clinics. The core product ecosystem comprises: (1) Rosagate Protocol system - professional and home-use products for rosacea management with RO-peptide 23 as the key innovation; (2) Enerpeel chemical peel range with patented carrier technology for conditions including rosacea and acne; (3) Tebiskin OSK - non-antibiotic acne solution evolved from the original Aknicare formulation; (4) Closebax for seborrhoeic dermatitis; (5) Derma FNS automated dermal needling system; (6) SkinMed Academy - Level 7 CPD-accredited training platform covering acne, rosacea, scarring, and pigmentation; (7) SkinMed Marketing Suite - clinical marketing and client acquisition support; and (8) SkinVital consumer vitamins. The company operates a business-to-business model, selling exclusively to medically-led clinics and offering comprehensive marketing support to drive new client footfall, particularly targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.
Differentiator
Problem solved
Functional benefit
Brands
- SkinMed Academy: CPD-accredited training platform offering Level 5 to 7 courses for healthcare professionals in acne, rosacea, and aesthetic treatments.
- ARAUK (Acne and Rosacea Association UK)
- Rosagate
- TripleLock® Rosacea Protocol
- Tebiskin OSK
- EnerPeel
- Closebax
Quantifiable outcome
- Over 80% of resistant acne patients achieved clear or significantly improved skin within 3 months
- +8 more outcomes
Companies that use SkinMed
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
SkinMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
SkinMed partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Professor Tony ChucoreProfessor Tony Chu serves as the lead instructor for SkinMed Academy's scarring masterclass and ARAUK accreditation programmes. He provides clinical expertise and educational content development. He also reviews difficult patients as a free diagnostic resource for clinics, contributing over 45 years of experience as lecturer, Professor, and President of the Acne and Rosacea Association UK.
- Acne and Rosacea Association UK (ARAUK)coreSkinMed is a proud sponsor of ARAUK and finances online training for clinics so clinicians can become experts in treating acne and rosacea. The charity accreditation programme is delivered through SkinMed Academy with Professor Tony Chu as President. SkinMed also contributes 50% towards the £300 ARAUK accreditation course fee for partner clinics.
- Top Teaching Hospitals Across EuropeminorClinical trials conducted in medical research facilities and top teaching hospitals across Italy, France, The Netherlands, Greece, Germany, and the UK, involving trials published and conducted by top dermatology Professors.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
SkinMed competitors and assessment
Company assessmentDirect peers
- Medik8: UK-headquartered professional skincare brand selling cosmeceutical formulations (vitamin C, retinoids, peels) through aesthetic clinics and dermatologists. Highly comparable B2B model targeting medically-led UK practices, with overlapping product categories (peels, vitamin A regimens) and a shared client base of clinic practitioners.
- ZO Skin Health: Dr. Zein Obagi-founded professional skincare brand sold exclusively through physicians and medical spas, offering protocols for acne, pigmentation, and anti-aging. Closely comparable physician-channel distribution model and protocol-based treatment philosophy.
- PCA Skin: Professional chemical-peel and skincare brand sold through licensed skincare professionals and medical practices. Overlaps on professional peels, acne and rosacea protocols, and the medically-led clinic distribution model.
- Alumier MD: Medical-grade professional skincare brand sold exclusively through trained skin professionals, with a portfolio covering acne, rosacea, hyperpigmentation, and aging. Highly comparable B2B-only distribution, professional training requirement, and indication overlap with SkinMed.
- iS Clinical: Cosmeceutical brand offering clinical-grade skincare and post-procedure products distributed through medical spas, dermatologists, and plastic surgeons. Overlapping professional-channel distribution and clinical-trial-backed efficacy claims.
Broad incumbents
- SkinCeuticals: L'Oréal-owned medical-grade skincare brand offering vitamin C serums, corrective creams, and post-procedure regimens dispensed through physician offices and medical spas. Comparable medical-grade positioning and clinic channel, though broader portfolio and far greater scale.
- Obagi Medical: Pharmaceutical-grade skincare company (now under Valeant/Bausch Health) selling tretinoin-based and hydroquinone systems through physicians for hyperpigmentation, acne, and anti-aging. Direct overlap on medically licensed prescription-strength positioning for chronic skin conditions.
Regional players
- Aesthetic Source: UK-exclusive distributor of professional skincare and aesthetic brands (e.g., SkinCeuticals, Obagi, iS Clinical, SkinTech) to medical aesthetic clinics. Comparable UK channel partner for medically-led practices, though as a multi-brand distributor rather than a proprietary brand.
- Healthxchange Group: UK-specialist pharmacy and distributor of aesthetic medical products, devices, and pharmaceuticals to clinics. Comparable UK-only channel reach into aesthetic practices and overlapping clinic-customer base, though focused on distribution rather than proprietary protocols.
Emerging players
- Skinbetter Science: Physician-dispensed skincare line developed by industry veterans, sold exclusively through authorized medical providers with patented delivery technologies — directly mirrors SkinMed's approach of combining proprietary chemistry with physician-only distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
SkinMed social profiles
Digital presenceSkinMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
SkinMed leadership team
Management profileNumber of profiles
SkinMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SkinMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SkinMed
What does SkinMed do?
SkinMed develops and supplies medically licensed skin treatment protocols, proprietary topical formulations, chemical peels, dermal needling devices, and clinically validated product ranges (Rosagate, Tebiskin OSK, Closebax, EnerPeel) exclusively to medically led aesthetic clinics in the UK. The company also operates the SkinMed Academy for CPD-accredited clinical training and a marketing suite that provides paid advertising, bespoke landing pages, and patient referral support to partner clinics.
Is SkinMed a public or private company?
SkinMed is a private company. It is classified as unknown and is currently operating.
When was SkinMed founded?
SkinMed was founded in 2021. It employs 11 to 50 people.
Where is SkinMed based?
SkinMed is headquartered in Harrogate, United Kingdom, in the Europe region.
How does SkinMed make money?
Three revenue lines are on record. Medical Product Sales are the primary driver. The others are professional Training Services and protocol Licensing.
Who are SkinMed's main competitors?
Direct peers on record are Medik8, ZO Skin Health, PCA Skin, Alumier MD and iS Clinical. Broad incumbents are SkinCeuticals and Obagi Medical. Regional players are Aesthetic Source and Healthxchange Group. Skinbetter Science is listed as an emerging player.
Does SkinMed have an API?
No public API is recorded for SkinMed.
What industry is SkinMed in?
SkinMed's product category is Medical Aesthetics Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 325412 and its SIC code is 2844.